Pathogenetic Rationale for Combination Therapy of Patients With Chronic Pancreatitis

Almanac of Clinical Medicine
doi 10.18786/2072-0505-2015-40-72-81
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Regional Research and Clinical Institute (MONIKI)

Related search

Homeostatic Disorders in Patients With Combination of Hypertonic Disease and Chronic Pancreatitis

Здобутки клінічної і експериментальної медицини
2017English

P335 ‘Lipid Triad ‘ in Patients With Chronic Pancreatitis in Combination With Arterial Hypertension

2019English

Chronic Pain Syndrome in Patients With Pancreatic Cancer: Individual Therapy and Its Pathogenetic Background

Russian Open Medical Journal
Medicine
2019English

Rationale for Combination Therapy of Chronic Myelogenous Leukaemia With Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning

British Journal of Cancer
Cancer ResearchOncology
2002English

Combination Therapy for PAH: Current Rationale, Future Concepts

Advances in Pulmonary Hypertension
2006English

Chronic Pancreatitis and Nutrition Therapy

Nutrition in Clinical Practice
MedicineNutritionDietetics
2019English

Immunomodulatory Effects of Combination Therapy With Bushen Formula Plus Entecavir for Chronic Hepatitis B Patients

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Mesenchymal Stem Cell Therapy for Acute and Chronic Pancreatitis

Journal of Gastroenterology
Gastroenterology
2017English

Clinical Effectiveness of ESWL/endoscopic Therapy for Painful Chronic Pancreatitis

Suizo
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy